FindTrial
Sign In

Genetic link in patients of parathyroid tumors with osteoporosis at a tertiary care hospital in western UP of India

Clinical Correlation of Single Nucleotide Polymorphism in Parathyroid Adenoma with Osteoporosis of Patients Attending a Tertiary Care Hospital in Western UP of India. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073522
Enrollment
30
Registered
2024-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E079- Disorder of thyroid, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Santosh University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with parathyroid adenoma and osteoporosis. Age: 45-55 Years

Exclusion criteria

Exclusion criteria: Patients with secondary causes of osteoporosis or parathyroid adenoma, comorbid conditions affecting bone health, and those receiving specific medications affecting bone metabolism.

Design outcomes

Primary

MeasureTime frame
Polymorphism in cyclin D1 in the study population in the state of Uttar Pradesh is expected in people under high risk of developing parathyroid adenoma.Timepoint: 1 year—

Secondary

MeasureTime frame
Demographic and clinical correlations, biochemical markers, BMD differences, fracture frequency, treatment response, and adenoma characteristicsTimepoint: one year—

Countries

India

Contacts

Public ContactDr Pawan Gupta

Max Super Speciality Hospital, A Unit of Crosslay Remedies Ltd.,

drpawan.oncosurgeon@gmail.com9811290152

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026